CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Study: Iboprofen May Reduce Heart Risks



December 14, 2004
There's new research showing that taking commonly used over-the-counter anti-inflammatory drugs could keep heart attacks at bay. The downside - abruptly stopping the therapy greatly increases heart attack risks.

The study, published in the Archives of Internal Medicine, examined the British General Practice Research Database over a six year period, finding that an increase in heart attacks could be traced to patients' stopping use of non-steroidal anti-inflammatory drugs (NSAIDs), a category of common medicines including ibuprofen, naproxen, ketoprofen and diclofenac.

According to the researchers, risk of heart attack increased 50% for patients who stopped taking the medicines up to 29 days before their first attack, compared with non-users. It said risk of heart attack in long-term NSAID users rose by more than 50% after they discontinued the drugs. Patients with inflammatory disease such as rheumatoid arthritis and lupus had three times the risk.

The study said that if subjects went 60 days after the stoppage with no event, the risk of heart failure was much less. It said NSAID medicines could help decrease heart attack risk by reducing inflammation, which is linked to heart attacks.

"The risk of AMI was not elevated for current NSAID users, suggesting that NSAIDs may counterbalance an increased risk caused by inflammation," according to the study.

The study looked at 8,688 cases of heart attack between 1995 and 2001, Nearly 34,000 control cases were also part of the study. It explored the over-the-counter drugs' effect on heart attack risk. Ibuprofen is sold under the brand-name Advil and naproxen as Aleve.

"Our results suggest that abrupt discontinuation of NSAID therapy may have to be avoided and that physicians should carefully review the disease status and the current medication profile before terminating a therapy with NSAIDs," the study concluded.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

August 29 2008

Recent Recalls & Safety Alerts



FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.



Back to the top |


Home | Complaint Form | News | Recalls | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds |


Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.